UNSPSC 51442417: Iofetamine i-123

This classification denotes a contrast media with the molecular formula C12H18IN, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) LV23B78IJC, chemically known as 1-(4-iodanylphenyl)-N-propan-2-ylpropan-2-amine but more generally known as Iofetamine i-123, which bears U.S. National Institutes of Health Compound Identifier 156375.

UNSPSC 51442417 Iofetamine i-123 is a Commodity code that appears in state and local procurement records with no recent activity directly aligned to its nominal scope. The two most recent opportunities tagged under this code—Broward County Aviation Department's RFI for Rapiscan X-ray system maintenance services (posted June 25, 2026) and Pasco County's indefinite-quantity solicitation for copper sulfate crystals and liquid copper sulfate (posted June 3, 2026)—do not involve iofetamine or radiopharmaceuticals. The mismatch suggests either miscoding at the issuing body or a lag in taxonomy alignment within state procurement systems. Neither opportunity reflects purchases of diagnostic radiopharmaceutical agents or imaging compounds that the code nominally describes.

Geographic activity limited to Florida counties in the recent record offers no signal of broader state or regional demand. With no solicitations actually procuring iofetamine i-123 or related radiopharmaceuticals in the source, the code shows little relevant recent state and local procurement activity. Business development professionals tracking nuclear medicine or diagnostic imaging supply chains should monitor this code going forward but may find value lying in parallel commodity codes that more accurately capture radiopharmaceutical procurement at state health departments, university hospital systems, or imaging centers.